Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Total Liabilities of $74.6 million for Q1 2026, up 6.35% sequentially from $70.1 million in Q4 2025, and up 565.61% YoY from $11.2 million in Q1 2025.
Camp4 Therapeutics (CAMP) Total Liabilities (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Total Liabilities for 4 years, with the latest figure at $74.6 million in Q1 2026.
- Quarterly Total Liabilities rose 565.61% year-over-year to $74.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $74.6 million (up 565.61% YoY) and the FY2025 annual result came in at $70.1 million, up 362.34% from the prior year.
- Total Liabilities advanced to $74.6 million in Q1 2026 per CAMP's latest filing, from $70.1 million in the prior quarter.
- Over five years, Total Liabilities peaked at $74.6 million in Q1 2026 and troughed at $11.2 million in Q1 2025.
- A 4-year average of $30.6 million and a median of $17.4 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Liabilities slipped 8.26% in 2024, then jumped 565.61% in 2026.
- Over 4 years, Total Liabilities stood at $16.5 million in 2023, then declined by 8.26% to $15.2 million in 2024, then surged by 362.34% to $70.1 million in 2025, then advanced by 6.35% to $74.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $74.6 million, $70.1 million, and $27.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | 94.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.12 Mn |
| Mar 31, 2026 | 74.56 Mn |
| Dec 31, 2025 | 70.10 Mn |
| Sep 30, 2025 | 27.73 Mn |
| Jun 30, 2025 | 11.29 Mn |
| Mar 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 15.16 Mn |
| Sep 30, 2024 | 18.19 Mn |
| Dec 31, 2023 | 16.53 Mn |